On-demand Therapy for Hereditary Angioedema

被引：3

作者：

Bernstein, Jonathan A. ^{[1
]}

机构：

[1] Univ Cincinnati, Allergy Sect, Div Immunol, Dept Internal Med,Coll Med, Cincinnati, OH 45267 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2013年 / 33卷 / 04期

关键词：

Hereditary angioedema; On-demand therapies; Berinert; Ecallantide; Icatibant; Ruconest; Guidelines; RECOMBINANT HUMAN C1-INHIBITOR; C1 INHIBITOR CONCENTRATE; ACUTE ATTACKS; RECEPTOR ANTAGONIST; CONESTAT ALPHA; MANAGEMENT; ECALLANTIDE; DEFICIENCY; ICATIBANT; EFFICACY;

D O I：

10.1016/j.iac.2013.07.004

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Consensus guidelines on hereditary angioedema (HAE) recommend that all patients have access to on-demand treatment of acute attacks. A recent patientcentric guideline recommended that at least 2 on-demand therapies be available because patients often have heterogeneous responses to different medications. Self-administration of therapeutic agents, or administration under supervision by a health care provider in the home setting, is the preferred treatment approach. Future studies are needed to show the benefits of acute on-demand therapies at improving quality of life and reducing morbidity and mortality in patients with HAE.

引用

页码：487 / +

页数：10

共 50 条

[1] Are hereditary angioedema patients satisfied with on-demand therapy with icatibant?
Beyaz, Sengul
Demir, Semra
Oztop, Nida
Colakoglu, Bahauddin
Buyukozturk, Suna
Gelincik, Asli
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 357 - 357
[2] Hereditary angioedema: On-demand treatment of angioedema attacks
Christiansen, Sandra C.
Zuraw, Bruce L.
ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 : S26 - S29
[3] Professional Administration Costs In The US For On-Demand Therapy Of Hereditary Angioedema
Machnig, Thomas
Zbrozek, Art
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB38 - AB38
[4] An evaluation of sebetralstat as the first oral on-demand therapy for Hereditary Angioedema
Farkas, Henriette
Balla, Zsuzsanna
EXPERT OPINION ON PHARMACOTHERAPY, 2025,
[5] Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
Riedl, M. A.
Farkas, H.
Aygoeren-Puersuen, E.
Psarros, F.
Soteres, D. F.
Staevska, M.
Cancian, M.
Hagin, D.
Honda, D.
Melamed, I
Savic, S.
Stobiecki, M.
Busse, P. J.
de Castro, E. Dias
Agmon-Levin, N.
Gower, R.
Kessel, A.
Kurowski, M.
Lleonart, R.
Panovska, V. Grivcheva
Wedner, H. J.
Audhya, P. K.
Hao, J.
Iverson, M.
Smith, M. D.
Yea, C. M.
Lumry, W. R.
Zanichelli, A.
Bernstein, J. A.
Maurer, M.
Cohn, D. M.
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (01): : 32 - 43
[6] Anxiety Associated With Parenteral On-demand Treatment For Hereditary Angioedema (HAE)
Burnette, Autumn
Anderson, John
Longhurst, Hilary
van Kooten, Sally
Heckmann, Markus
Danese, Sherry
Goga, Ledia
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB141 - AB141
[7] Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks
Wedner, H. James
Radojicic, Cristine
Ulloa, Julie
Danses, Sherry
Desai, Vibha
Czado, Shawn
Audhya, Paul
Christiansen, Sandra
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB85 - AB85
[8] Patterns of On-Demand Medication Use in the Treatment of Hereditary Angioedema Attacks: Implications for the Management of Hereditary Angioedema in the Emergency Department
Chiao, J.
Levy, D. S.
Feuersenger, H.
Dang, J.
Pines, J.
ANNALS OF EMERGENCY MEDICINE, 2018, 72 (04) : S56 - S56
[9] Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines
Cohn, Danny M.
Soteres, Daniel F.
Craig, Timothy J.
Lumry, William R.
Magerl, Markus
Riedl, Marc A.
Audhya, Paul K.
Maurer, Marcus
Bernstein, Jonathan A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (03) : 726 - 739
[10] Novel Long-Term Prophylactic and On-Demand Therapies for Hereditary Angioedema
Wu, Ashley Y.
Banerji, Aleena
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (03): : 715 - 717

← 1 2 3 4 5 →